Skip to main content
SpringerLink
Log in

Treatment of chronic inflammatory demyelinating polyneuropathy

  • Review
  • Published:
The Italian Journal of Neurological Sciences Aims and scope Submit manuscript

Abstract

The management of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the main topic of this review. A few comments will also be made about treatment of the demyelinating form of paraproteinaemic demyelinating polyneuropathy (PDN) and of multifocal motor neuropathy (MMN). The review briefly describes the main characteristics of these neuropathies, and examines case series and trials which evaluated the principal therapeutic strategies for CIDP, PDN and MMN, such as intravenous immunoglobulin (IVIg) therapy, steroid treatment, plasma exchange and immunosuppressor administration. Controlled trials demonstrated that IVIg, steroid treatment and plasma exchange are effective in CIDP. For PDN the therapeutic strategies are the same as for idiopathic CIDP, but usually the clinical response is poorer. For MMN, IVIg therapy is definitely the first choice treatment.

Sommario

Lo scopo principale di questa review è di esaminare le strategie terapeutiche nella neuropatia infiammatoria cronica demielineizzante (CIDP). Alcuni commenti vengono fatti anche riguardo il trattamento della forma demielinizzante della neuropatia demielinizzante paraproteinemica (PDN) e della neuropatia motoria multifocale (MMN). La review delinea le principali caratteristiche cliniche delle diverse forme di neuropatia demielinizzante ed esamina i principali studi clinici, controllati e non controllati, che hanno valutato il trattamento deila CIDP e della PDN e MMN con immunoglobuline endovena (IVIg), con la terapia steroidea, la plasmaferesi e farmaci immunosoppressori. Studi controllati hanno dimostrato che le IVIg, to steroide e la plasmaferesi sono efficaci nella CIDP. Per quanto riguarda la PDN le strategic terapeutiche sono analoghe a quelle adottate nella CIDP anche se la risposta clinica è solitamente meno evidente. Infine, nella MMN le IVIg sono sicuramente il trattamento di prima scelta.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hartung HP, Reiners K, Toyka KV, Pollard JD (1994) Giullain-Barrè syndrome and CIDP. In: Hohlfeld R (ed) Immunological neuromuscular disorders. Kluwer, Dordrecht, pp 33–104

    Google Scholar 

  2. Prineas JW, Mcleod JG (1976) Chronic relapsing polyneuritis. J Neurol Sci 27:427–458

    Google Scholar 

  3. Koski CL, Humphrey R, Shin ML (1985). Anti-peripheral myelin antibody in patients with demyelinating neuropathy: Quantitative and kinetic determination of serum antibody by complement component I fixation. Proc Natl Acad Sci USA 82:905–909

    Google Scholar 

  4. Van Doorn PA, Brand A, Vermeulen M (1987) Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy. Neurology 37:1798–1802

    Google Scholar 

  5. Fredman P, Vedeler CA, Nyland H et al (1991) Antibodies in antisera from patients with inflammatory demyelinating poliradiculo-neuropathy react with ganglioside LM1 and sulfatide of peripheral nerve myelin. J Neurol 238:76–79

    Google Scholar 

  6. Conolly AM, Pestronk A, Trotter JL et al (1993) High titer selective serum anti β tubulin antibodies in chronic inflammatory demyelinating polyneuropathy. Neurology 43:557–562

    Google Scholar 

  7. Simone IL, Annunziata P, Maimone D (1993) Serum and CSF antibodies to ganglioside GM1 in Guillain-Barré syndrome and chronic inflammatory polyneuropathy. J Neurol Sci 114:49–55

    Google Scholar 

  8. Saida K, Sumner AJ, Saida T (1980) Antiserum mediated demyelinization: Relationship between remyelinization and functional recovery. Ann Neurol 8:12–24

    Google Scholar 

  9. Saida T, Saida K, Lisak RP, Brown MJ et al (1982) In vivo demyelinating activity of sera from patients with Guillain-Barrè syndrome. Ann Neurol 11:69–75

    Google Scholar 

  10. Heininger K, Liebert UG, Toyka KV, Haneveld FT et al (1984) Chronic inflammatory demyelinating polyradiculoneuropathy. Reduction of nerve conduction velocities in monkeys by sistemic passive transfer of immunoglobulin G. J Neurol Sci 66:1–14

    Google Scholar 

  11. Lassmann H, Fierz W, Neuchrist C et al (1991) Chronic relapsing esperimental allergic neuritis induced by repeated transfer of P2-protein reactive T cell lines. Brain 144:429–442

    Google Scholar 

  12. Van Doorn PA, Vermeulen M, Brand A, Mulder PGH, Busch HFM (1991) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement. Arch Neurol 48:217–220

    Google Scholar 

  13. McCombe PA, Pollard JD, McLeod JG (1987) Chronic inflammatory demyelinating polyradiculoneuropathy: A clinical and electrophysiological study of 92 cases. Brain 110:1617–1630

    Google Scholar 

  14. Gorson KC, Allam G, Ropper AH (1997) Chronic inflammatory demyelinating polyneuropathy: Clinical feature and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48:321–328

    Google Scholar 

  15. Dyck PJ, Lais AC, Ohta M et al (1975) Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50:621–637

    Google Scholar 

  16. Barohn RJ, Kisser JT, Warmolts JR, Mendell JR (1989) Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46:878–884

    Google Scholar 

  17. Hughes RAC (1990) Guillain-Barrè syndrome. Springer, Berlin Heidelberg New York

    Google Scholar 

  18. Cornblath DR, Chaudry V, Griffin JW (1991) Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Ann Neurol 30:104–106

    Google Scholar 

  19. Dyck PJ, Prineas J, Pollard J (1993) Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Griffin JW, Low A, Poduslo JF (eds) Peripheral neuropathy, 3rd edn. WB Saunders, Philadelphia, pp 1498–1517

    Google Scholar 

  20. Ad Hoc Subcommittee of the American Academy of Neurology (1991) AIDS Task Force: Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41:617–618

    Google Scholar 

  21. Albers J, Kelly J (1989) Aquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic features. Muscle Nerve 12:435

    Google Scholar 

  22. Simmons Z, Albers JW, Bromberg MB, Feldman EL (1995) Long term follow-up of patients with chronic inflammatory demyelinating polyneuropathy without and with monoclonal gammopathy. Brain 118:359–368

    Google Scholar 

  23. Nevo Y, Pestronk A, Kornberg AJ, Connolly AM et al (1996) Childhood chronic inflammatory demyelinating neuropathies: Clinical course and long term follow-up. Neurology 47:98–102

    Google Scholar 

  24. Austin JH (1958) Recurrent polyneuropathies and their corticosteroid treatment. With five-year observation of a placebocontrolled case treated with corticotropin, cortisone, and prednisone. Brain 81:157–192

    Google Scholar 

  25. Dyck PJ, O'Brien PC, Oviatt KF, Dinapoli RP, Daube JR, Bartleson JD et al (1982) Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11:136–141

    Google Scholar 

  26. DeVivo DC, Engel WK (1970) Remarkable recovery of steroid-positive recurrent polyneuropathy. J Neurol Neurosurg Psychiatry 33:62–69

    Google Scholar 

  27. Levy RL, Newkirk R, Ochoa J (1979) Treating chronic relapsing Guillain-Barrè syndrome by plasma exchange (letter). Lancet 2:259–260

    Google Scholar 

  28. Server AC, Lefkowith J, Braine H, McKhann GM (1979) Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange. Ann Neurol 6:258–261

    Google Scholar 

  29. Toyka KV, Augspach R, Wietholter H, Besinger UA et al (1982) Plasma exchange in chronic inflammatory polyneuropathy: Evidence suggestive of pathogenic humoral factor. Muscle Nerve 5:479–484

    Google Scholar 

  30. Dyck PJ, Daube J, O'Brien P et al (1986) Plasma exchange in chronic inflammatory demyelinating polyneuropathy. N Engl J Med 314:461–465

    Google Scholar 

  31. Hahn AF, Bolton CF, Pillay N, Chalk C et al (1996) Plasmaexchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind sham controlled cross-over study. Brain 119:1055–1066

    Google Scholar 

  32. Heininger K, Gibbels K, Besinger UA, Borberg H et al (1990) Role of therapeutic plasmapheresis in chronic inflammatory demyelinating polyradiculoneuropathy. In: Rock G (ed) Apheresis. Wiley-Liss, New York, pp 275–281

    Google Scholar 

  33. Thornton CA, Griggs RC (1994) Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease (review). Ann Neurol 35:260–268

    Google Scholar 

  34. Fanaroff AA, Korones SB, Wright LL et al (1994) A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 330:1007–1013

    Google Scholar 

  35. Schwarzt SA (1993) Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes. Clin Rev Allergy Immunol 10:1–12

    Google Scholar 

  36. Ronda N, Hurez V, Kazatchine MD (1993) Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases. Vox Sang 65:65–72

    Google Scholar 

  37. Sullivan KM, Kopecky KJ, Jocom J et al (1990) Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation N Engl J Med 323:705–712

    Google Scholar 

  38. Huang-Xuan K, Leger JM, Younes-Chennoufi B et al (1993) Traitment des neuropathies dusimmunitaires par immunoglobulines polyvalents intraveineuses. Rev Neural 149:385–392

    Google Scholar 

  39. Faed JM, Day B, Pollock M, Taylor PK, Nukada H, Hammond-Tooke GD (1989) High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy. Neurology 39:422–425

    Google Scholar 

  40. Hodkinson SJ, Pollard JD, McLeod JG (1990) Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 53:327–330

    Google Scholar 

  41. Nemni R, Fazio S, Fazio R, Galardi G, Previtali S, Comi G (1994) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments. J Neurol Neurosurg Psychiatry 57(Suppl):43–45

    Google Scholar 

  42. Vermeulen M, Van Doorn PA, Brand A, Strengers PFW, Jennekens FGI, Busch HFM (1993) Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: A double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 56:36–39

    Google Scholar 

  43. Dyck PJ, Litchy WJ, Kratz KM et al (1994) A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36:838–845

    Google Scholar 

  44. Hahn AF, Bolton CF, Pillay N, Chalk C et al (1996) Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo controlled, cross-over study. Brain 119:1067–1077

    Google Scholar 

  45. Kahn SN, Riches PG, Kohn J (1980) Paraproteinemia in neurological disease: Incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol 33:617–621

    Google Scholar 

  46. Kelly JJ, Kyle RA, O'Brien PC, Dyck PJ (1981) Prevalence of monoclonal protein in peripheral neuropathy. Neurology 31:1480–1483

    Google Scholar 

  47. Krol V, Straaten MJ, Ackerstaff RG, DeMaat CE (1985) Peripheral polyneuropathy and monoclonal gammopathy of undetermined significance. J Neurol Neurosurg Psychiatry 48(7):706–708

    Google Scholar 

  48. Osby E, Noting L, Hast R, Kjellin KG, Knutsson E, Siden A (1982) Benign monoclonal gammopathy and peripheral neuropathy. Br J Haematol 51(4):531–539

    Google Scholar 

  49. Vrethem M, Cruz M, Huang W, Malm C, Holmgren H, Ernerudh J (1993) Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies. J Neurol Sci 114:193–199

    Google Scholar 

  50. Nobile-Orazio E, Manfredini E, Carpo M et al (1994) Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36:416–424

    Google Scholar 

  51. Dalakas MC, Engel WK (1981) Polyneuropathy with monoclonal gammopathy: Studies of 11 patients. Ann Neurol 10:45–52

    Google Scholar 

  52. Kelly JJ, Adelman E, Berkman E, Bhan I (1988) Polyneuropathies associated with IgM monoclonal gammopathies. Arch Neurol 45:1355–1359

    Google Scholar 

  53. Yeung KB, Thomas PK, King RHM et al (1991) The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol 238:383–391

    Google Scholar 

  54. Nobile-Orazio E, Baldini L, Barbieri S et al (1988) Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann Neurol 24:93–97

    Google Scholar 

  55. Waterston JA, Brown MM, Ingram DA, Swash M (1992) Cyclosporin A therapy in paraprotein-associated neuropathy. Muscle Nerve 15:445–448

    Google Scholar 

  56. Dellagi K, Chedru F, Clauvel JP, Brouet JC (1984) Neuropathie periphédrique de la macroglobulinemie de Waldenstrom. Presse Med 13:1199–1201

    Google Scholar 

  57. Sherman WH, Olarte MR, McKiernan G, Sweeney K, Latov N, Hays AP (1984) Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J Neurol Neurosurg Psychiatry 47:813–819

    Google Scholar 

  58. Simmons Z, Bromberg MB, Feldman EL, Blaivas M (1993) Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance. Muscle Nerve 16:77–83

    Google Scholar 

  59. Dyck PJ, Low PA, Windebank AJ et al (1991) Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 325:1482–1486

    Google Scholar 

  60. Ellie E, Vital A, Steck A, Boiron JM, Vital C, Julien J (1996) Neuropathy associated with “benign” anti-myelin-associated glycoprotein IgM gammopathy: Clinical, immunological, neurophysiological, pathological findings and response to treatment in 33 cases. J Neurol 243:34–43

    Google Scholar 

  61. Oksenehendler E, Chevret S, Léger JM et al (1995) Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. J Neurol Neurosurg Psychiatry 59:243–247

    Google Scholar 

  62. Cook D, Dalakas M, Galdi A, Biondi D, Porter H (1990) High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. Neurology 40:212–214

    Google Scholar 

  63. Léger JM, Younes-Chennoufi AB, Chassande B et al (1994) Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry 57(Suppl):46–49

    Google Scholar 

  64. Notermans NC, Lokhorst HM, Frassen H, Van Der Graaf Y, Teunissen LL, Jennekens FG, Van Den Berg LH, Wokke JH (1996) Neurology 47(5):1227–1233

    Google Scholar 

  65. Blume G, Pestronk A, Goodnough LT (1995) Anti-MAG antibody-associated polyneuropathies: Improvement following immunotherapy with monthly plasma-exchange and IV cyclophosphamide. Neurology 45(8):1577–1180

    Google Scholar 

  66. Kaji R, Hirota N, Oka N et al (1994) Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy. Muscle Nerve 17:108–110

    Google Scholar 

  67. Corse AM, Chaudry V, Crawford TO, Cornblath D, Kuncl R, Griffin J (1996) Sensory nerve pathology in multifocal motor neuropathy. Ann Neurol 39:319–325

    Google Scholar 

  68. Lange DJ, Trojaborg W, Latov N, Hays AP, Younger DS, Uncini A, Blake DM, Hirano M, Burns SM, Lovelace RE et al (1992) Multifocal motor neuropathy with conduction block: Is it a distinct clinical entity? Neurology 43(3 Pt 1):497–505

    Google Scholar 

  69. Kornberg AJ, Pestronk A (1994) The clinical and diagnostic role of anti-GMI antibody testing. Muscle Nerve 17(1):100–104

    Google Scholar 

  70. Feldman EL, Bromberg MB, Alberts JW, Pestronk A (1991) Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 30:397–401

    Google Scholar 

  71. Krarup C, Stewart JD, Sumner AJ, Pestronk A, Lipton SA (1990) A syndrome of asymmetric limb weakness with motor conduction block. Neurology 40:118–127

    Google Scholar 

  72. Parry GJ, Clarke S (1988) Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 11:103–107

    Google Scholar 

  73. Pestronk A, Cornblath DR, Ilyas AA et al (1988) A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24:73–78

    Google Scholar 

  74. Donaghy M, Mills KR, Boniface SJ, Simmons J, Wright I, Gregson N, Jacobs J (1994) Pure motor demyelinating neuropathy: Deterioration after steroid treatment and improvement with intravenous immunoglobulin J Neurol Neurosurg Psychiatry 57(7):778–783

    Google Scholar 

  75. Van Den Berg LH, Lokhorst H, Wokke JH (1997) Neurology 48(4):1135

    Google Scholar 

  76. Bouche P, Moulonguet A, Younes-Chennoufi AB et al (1995) Multifocal motor neuropathy with conduction block: A study of 24 patients. J Neurol Neurosurg Psychiatry 59:38–44

    Google Scholar 

  77. Chaudry V, Corse AM, Cornblath DR et al (1993) Multifocal motor neuropathy: Response to human immune globulin. Ann Neurol 33:237–242

    Google Scholar 

  78. Comi G, Amadio S, Galardi G, Fazio R, Nemni R (1944) Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 57(Suppl):35–37

    Google Scholar 

  79. Kaji R, Shibasaki H, Kimura J (1992) Multifocal demyelinating motor neuropathy: Cranial nerve involvement and immunoglobulin therapy. Neurology 42:506–509

    Google Scholar 

  80. Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G (1993) High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 43:537–544

    Google Scholar 

  81. Parry GJ (1996) AAEM case report # 30: Multifocal motor neuropathy. Muscle Nerve 19:269–276

    Google Scholar 

  82. Azulay JP, Blin O, Pouget J et al (1994) Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study. Neurology 44:429–432

    Google Scholar 

  83. Van Den Berg LH, Kerkoff H, Oey PL et al (1995) Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: A double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 59:248–252

    Google Scholar 

  84. Azulay JP, Rihet P, Pouget J, Cador F, Blin O, Boucraut J, Serratrice G (1997) Long term follow up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry 62(4):391–394

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department Clinical Neurophysiology, University of Milano, Scientific Institute Hospital San Raffaele, Via Olgettina 60, I-20132, Milano, Italy

    G. Comi & L. Roveri

Authors
  1. G. Comi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Roveri
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Comi, G., Roveri, L. Treatment of chronic inflammatory demyelinating polyneuropathy. Ital J Neuro Sci 19, 261–269 (1998). https://doi.org/10.1007/BF00713851

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00713851

Key words

Search

Navigation